Position in ANNX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$23,052,371
+$4,339,233 QoQ
Shares Held
4,037,193
+19.5% QoQ
Ownership
1.97%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#13
of 216 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ANNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,877,569,550 across 521 Biotechnology names. ANNX ranks #121 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in ANNX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $23,052,371 | 4,037,193 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $18,713,138 | 3,377,823 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $14,572,536 | 2,902,896 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $7,432,679 | 2,436,944 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $5,483,455 | 2,284,773 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $4,332,868 | 2,245,010 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $11,139,681 | 2,171,478 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $12,690,318 | 2,143,635 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $8,880,592 | 1,812,366 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $10,249,414 | 1,429,486 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $4,186,933 | 922,232 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $2,075,896 | 879,617 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $3,109,955 | 883,510 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,490,269 | 387,083 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,923,586 | 372,067 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $2,251,367 | 364,299 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $926,353 | 245,717 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,404,396 | 514,431 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $5,517,589 | 480,208 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $7,910,050 | 425,043 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $9,133,027 | 405,732 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $10,081,810 | 362,134 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $6,223,584 | 248,645 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $6,920,160 | 228,917 | Shares | Defined | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||